Tavros Therapeutics + KdT BULL CITY BIOBUCKS Join us for a fireside chat with Tavros Therapeutics who signed a $930M deal with Bayer in October 2022 on only $3M in equity financing. How the F$#% did they do that? Eoin McDonnell, CEO of Tavros, will breakdown the inner workings of engineering a successful major pharmaceutical partnership.
Consumer Innovation In this session explore consumer focused scientific innovation in animal and human health, gaming, and e-commerce. FEATURED COMPANIESAja Labs, Osahon OjeagaAniluxx Biotechnology, Stefan C WeissJabin Beverage Co, Homayoon ErshadiMomtech, Hal EasonNyssa Care, Eden LaurinRarebird, Jeffrey DietrichWH Farms Co., Q. Nicole VanderhorstWisely, Rachelle McCray
Diagnostics, Tools + Platforms In this session, explore new laboratory tools and therapeutic platform technology. FEATURED COMPANIESAltopa, Nicole WickerCoprata, Brian StonerGlycan Therapeutics, Jian LiuIntake Health, Michael BenderPhosphoGam, Dr. Richard LopezQatch Technologies, Zehra ParlakRedbud Labs, Richard SperoZymtronix, Stephane Corgie
Banking Uncertainty? A Better Understanding of Banking and Treasury Management Option Silicon Valley Bank has been an integral partner in the venture community for 40 years. Its sudden collapse has caused anxious moments for founders, bankers, and venture funds for the past several weeks. Hear from Brad Schomber, CFO at Get Spiffy, Nikki Heron CFO at Tavros Therapeutics, Dara Keatts Director of Innovation Banking at CIBC, […]